CTRI/2024/07/070458尚未招募2 期
ow dose Oral Metronomic Cyclophosphamide and Etoposide combination in Recurrent/Refractory High Grade Endometrial Cancer, a Single Arm Phase 2 Study
Dr Bhoor Singh0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Histologically confirmed recurrent / refractory high grade endometrial cancer [endometroid/serous/carcinosarcoma/clear cell]
- •2.One or more prior lines of therapy with at least one platinum based chemotherapeutic regimen, containing carboplatin or cisplatin with platinum free interval of less than 1 year.
- •3.Written informed consent.
- •4.ECOG PS 0-2
- •5.Measurable disease with at least one target lesion which could be used for response evaluation as per RECIST 1.1 criteria
- •6.Adequate organ function
排除标准
- •1.Low grade [grade I/II] endometrial cancer
- •2.Patient who are eligible for hormonal therapy
- •3. Patients with recurrent carcinoma endometrium with platinum free interval of more than 1 year
- •4.Chemotherapy naïve patient [adjuvant/metastatic setting]
- •5.Patients who are eligible/affordable for immunotherapy
研究者
相似试验
招募中
不适用
Comparative Study of Oral Cyclophosphamide and Mycophenolate mofetil in Childhood Nephrotic SyndromeCTRI/2021/06/034421GURDEEP SINGH DHOORIA
已完成
2 期
Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate CancerProstate CancerNCT00176605Rutgers, The State University of New Jersey15
尚未招募
不适用
Effectiveness and safety of cyclophosphamide for older microscopic polyangiitis patients on induction therapyJPRN-UMIN000043514Department of Nephrology & Dialysis Kitano Hospital, Tazuke Kofukai Medical Research Institute35
进行中（未招募）
1 期
Study with the aim to compare a chemotherapy based on low doses of oral cyclophosphamide administered daily vs standard doxorubicin in elderly patients with advanced soft tissue sarcomas.soft tissue sarcomasMedDRA version: 20.0Level: PTClassification code 10075333Term: Soft tissue sarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-001075-20-ITISTITUTO ONCOLOGICO VENETO - IRCCS132
进行中（未招募）
不适用
_advanced solid tumor with bone metastasis and advanced pretreated osteosarcoma.EUCTR2014-000196-85-FRInstitut Bergonié